pcc Practice Builder™ Emerges as a Growth Engine for Medical Practices in 2026
Therap Services Enhances Individual Plan Workflows to Boost Efficiency and Improve User Experience
Bausch Health Announces Final Results and Expiration of Exchange Offers
CASI Pharmaceuticals Receives Extension from Nasdaq to Meet Listing Requirements
A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors
AUSTIN, Tex., April 26, 2022 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company, today announced it will...
CAMBRIDGE, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that the...
Seamless, Comprehensive Capabilities Eliminate Barriers to Microbiome ResearchRENSSELAER, N.Y., April 26, 2022 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader...
Company continues innovating preclinical tools used in new and ongoing small animal research and product development with SmartStudy™ SmartStudy Technology...
Tampa, April 26, 2022 (GLOBE NEWSWIRE) -- Alcohol Awareness Month began in 1987 and was formerly funded through the National...
Four ARVO presentations accepted will feature data from APX3330 Phase 2b trial in Diabetic Retinopathy and Nyxol® Phase 2 trial...
Gold Award Recognizes Antibody TestRARITAN, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Ortho Clinical Diagnostics (NASDAQ: OCDX), one of the world's...
Minerva calls on women to talk about their periodsSANTA CLARA, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Minerva Surgical, Inc....
DUBLIN, Ireland and BRIDGEWATER, N.J., April 26, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) announced today its partner HLS...
DURHAM, N.C., April 26, 2022 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in...
GB0139 is Galecto’s proprietary inhaled once-daily small molecule galectin-3 inhibitor GALACTIC-1 trial on track to deliver top-line results in mid-2023...
Senior Director of Marketing Theresa Ferguson selected as marketing lead for Predictive OncologyEAGAN, Minn., April 26, 2022 (GLOBE NEWSWIRE) --...
DENVER, April 26, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative...
Conference Call on Tuesday, May 10, 2022 at 8:30 a.m. ETLEXINGTON, Mass., April 26, 2022 (GLOBE NEWSWIRE) -- Agenus (NASDAQ:...
FREMONT, CA, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical...
PRX012 is a potential best-in-class, subcutaneous anti-amyloid beta antibody therapy currently in a Phase 1 clinical study for the treatment...
BASEL, Switzerland, April 26, 2022 (GLOBE NEWSWIRE) -- Myovant Sciences (NYSE: MYOV) today announced it will host a webcast and conference...
Physicians To Have Pre-Approval/Expanded Access to Galinpepimut-S (GPS) for Treatment of Patients with Acute Myeloid Leukemia (AML)NEW YORK, April 26,...
MINNEAPOLIS, April 26, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for...
IRVINE, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet...
